Research banner image (1150 x 300)

Katy O. and Paul M. Rady Esophageal and Gastric Center of Excellence

The Katy O. and Paul M. Rady Esophageal and Gastric Center of Excellence was established in late 2022 in the hopes of advancing esophageal and gastric cancer research, clinical trials, screening, and treatments. This Center of Excellence was established through a generous gift from the Rady family in honor of their late family member, Paul R. O’Hara II, who was treated at the University of Colorado Cancer Center.

The Esophageal and Gastric Cancer Multidisciplinary Clinic brings together a team of expert surgeons, gastroenterologists, pathologists, oncologists, radiologists, and more focused on the esophagus and stomach. Together, the team analyzes a patient’s diagnosis and recommends a specific treatment plan for the individual. Not only does the clinic focus on patients with precancerous and cancerous lesions of the esophagus and stomach, but they have also established a benign clinic that has a specialized team who treats patients with noncancerous conditions of the esophagus.

The Center of Excellence is committed to providing the best possible care to all its patients, initiating new research, as well as investigating new clinical trials. The center works with the University of Colorado Cancer Center and across the institution, including UCHealth.

Naming Ceremony

Celebrating the naming of the Center (2022). Left to right, Dr. Madeleine Kane, Dr. Richard Schulick, Paul Rady, Katy Rady, Dr. Sachin Wani

If you are interested in collaborating with other individuals across the campus who focus on esophageal and gastric cancer and noncancerous conditions, please submit your interest below:

Meet the Executive Director

Sachin Wani, MD
The Center of Excellence is led by Sachin Wani, MD, professor of medicine in the Division of Gastroenterology and Hepatology at the CU School of Medicine, who holds the Katy O. and Paul M. Rady Endowed Chair in Esophageal Cancer Research. Wani’s goals include using an endowed innovation fund for seed grants, student support, and other high-priority programs, recruiting top talent and infrastructure for innovation and new programs, developing and expanding clinical trials, and expanding and bolstering existing screening and surveillance programs that will lead to better patient results and fewer deaths from esophageal and gastric cancers.

Research Studies (Clinical Trials)

The research studies (clinical trials) below are open to enrollment.

Abbreviations used below

BE — Barrett’s Esophagus

Barrett's Esophagus (BE) is a condition in which tissue that is similar to the lining of your intestine replaces the tissue lining your esophagus. It is a common condition associated with chronic gastroesophageal reflux disease. BE is the only known precursor to esophageal adenocarcinoma (EAC); see below.

EAC — esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) is a highly lethal cancer with an increasing incidence over the last 5 decades.

EGD — Esophagogastroduodenoscopy

An esophagogastroduodenoscopy (EGD) is a procedure that allows your physician to visualize the inside of your oropharynx, esophagus, stomach, and duodenum.

Other terms to know


Dysplasia refers to abnormal cell structure within the esophageal lining. Progressing by severity:

Non-dysplastic BE   Low Grade Dysplasia   High Grade Dysplasia   EAC

Latest in Esophageal Cancer from the CU Cancer Center

Loading items....

Contact Us


Jessica Dry, MHA
Program Manager

Maddie Taylor, MSHA
Program Coordinator


Kelli DeLay, MD
Medical Director, Benign Esophageal and Gastric Multidisciplinary Clinic

Megan Marsh, MPAS, PA-C
Esophageal and Gastric Multidisciplinary Clinic Coordinator


Case Brennan, BA
Research Services Professional

Jazmyne Gallegos, BA
Research Services Professional 

CMS Login